MiniMed Appoints Alcon CEO David Endicott and Linnea Burman to Board of Directors

MiniMed Announces That Alcon CEO David Endicott and Linnea Burman Have Joined Its Board of Directors, Effective Immediately, Increasing the Number of Board Members from 9 to 11David EndicottWill serve as a member of the Board’s Compensation and Talent Committee.

Executive Evaluation

“David has had similar experiences before. He brings decades of operational leadership experience in the healthcare industry, extensive expertise in managing publicly listed companies, and firsthand practical knowledge essential for driving transformational leadership and building growth. This is particularly valuable at Medtronic as it strengthens its execution capabilities as an independent company.”

---Que Dallara  MiniMedChief Executive Officer

David Endicott's Resume

David Endicott is a seasoned executive with extensive experience in the healthcare sector, having held leadership roles at multiple global pharmaceutical and medical device companies. As the current CEO of Alcon, he possesses deep insights into both Alcon and the broader healthcare industry. He joined Alcon in July 2016, when it was still a division of Novartis Pharmaceuticals, serving as Chief Operating Officer; in July 2018, he was appointed CEO and led Alcon’s spin-off and public listing. Prior to joining Alcon, David EndicottFormerly served as President of Hospira Infusion Systems, a Pfizer subsidiary. Prior to joining Hospira, David EndicottDavid Endicott served as an executive and member of the Executive Committee at Allergan, where he worked for over 25 years, holding various leadership positions across the United States, Europe, Asia, and Latin America.He previously served as a director of Zeltiq and Orexigen Therapeutics. Currently, he serves as a director of the Advanced Medical Technology Association (AdvaMed).

David Endicott's Testimonial

I am honored to join MiniMed at this pivotal moment in the company’s development.Board of Directors. MiniMed“With a long and distinguished history in the field of diabetes, we have a clear opportunity to simplify care for more people. I look forward to working with Kui, the Board of Directors, and the leadership team to advance the company’s technological progress and expand its global impact.”

Linnea Burman Resume

Linnea BurmanCurrently serves as Senior Vice President of Medtronic and President of the Neurovascular business. During her more than 19 years at Medtronic, she has held multiple senior operational and strategic leadership roles, including Vice President and General Manager (Enabling Technologies, Cranial & Spinal Technologies) and Vice President and General Manager (Pelvic Health & Gastric Therapies).